Dr. Luis Malpica Castillo, MD
Claim this profileClinical Trials Luis Malpica Castillo, MD is currently running
More about Luis Malpica Castillo, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Luis Malpica Castillo, MD has experience with
- Golidocitinib
Breakdown of trials Luis Malpica Castillo, MD has run
Peripheral T-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Luis Malpica Castillo, MD specialize in?
Luis Malpica Castillo, MD focuses on Peripheral T-Cell Lymphoma and other conditions. In particular, much of their work with Peripheral T-Cell Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Luis Malpica Castillo, MD currently recruiting for clinical trials?
Yes, Luis Malpica Castillo, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Luis Malpica Castillo, MD has studied deeply?
Yes, Luis Malpica Castillo, MD has studied treatments such as Golidocitinib.
What is the best way to schedule an appointment with Luis Malpica Castillo, MD?
Apply for one of the trials that Luis Malpica Castillo, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.